abstract |
Disclosed are compounds of the formula (I), useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. n n n n n n n n n n Also disclosed are intermediates thereof, and methods of making and methods of using same. |